Organization · Venture Capital
GreyBird Ventures, LLC
GreyBird Ventures, LLC is a U.S.-based venture capital firm specializing in early-stage investments in diagnostic technologies for precision medicine. The firm focuses on high-specificity diagnostics that enhance patient care and healthcare efficiency.
Overview
What GreyBird Ventures, LLC does
What GreyBird Ventures, LLC is
GreyBird Ventures, LLC is a U.S.-based venture capital firm specializing in early-stage investments in diagnostic technologies for precision medicine. The firm focuses on high-specificity diagnostics that enhance patient care and healthcare efficiency.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find GreyBird Ventures, LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
GreyBird Ventures, LLC as a funder
Investment thesis
GreyBird Ventures focuses on high-specificity diagnostics that enhance precision medicine, moving healthcare away from trial-and-error treatment towards personalized and predictive approaches.
Focus narrative
GreyBird Ventures invests in companies that create high-specificity diagnostic technologies. The firm emphasizes early-stage investments that have the potential to significantly change healthcare standards, aiming to eliminate trial-and-error medicine and enhance patient outcomes.
Value beyond capital
GreyBird Ventures provides engaged diligence, working closely with portfolio companies before and after investment. This includes board involvement, clinical-trial planning, technical problem solving, and strategic partner introductions, ensuring that companies receive comprehensive support to navigate the complexities of the healthcare landscape.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Healthcare · Biotech · Precision Medicine · Medical Devices
- Regions
- Global · North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Angstrom Bio: Innovating in the field of precision diagnostics. Platomics: Engaged in partnerships related to IVDR documentation and NGS workflow compliance. GNA Biosolutions: Focused on advanced diagnostic solutions. JF Healthcare: Developing healthcare technologies. NeuroKaire: A precision psychiatry company personalizing treatments for brain health. Atlas5D: Specializing in technology for measuring movement and behavior. Hummingbird Diagnostics: Innovating in diagnostic technologies. Ceres Nano: Involved in the commercialization of diagnostic tests.
Common questions
What to know about GreyBird Ventures, LLC
Upseed classifies GreyBird Ventures, LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.